FIELD: medicine, laboratory diagnostics. SUBSTANCE: one should use 0.02 ml erythrocytes obtained out of patient's blood to prepare 5%- erythrocytic suspension in saline buffer at ions concentration being equal to that in blood plasma, filtrate erythrocytic suspension through microporous membrane without any environmental impact for 1 min, detect spectrophotometrically hemoglobin quantity both in filtered suspension and in suspension before filtration to calculate erythrocytic deformity value (EDV) by the following formula: EDV = Hb filtrate/Hb 5%-erythrocytic suspension, where Hb filtrate - quantity of hemoglobin in suspension before filtration, and compare the obtained value with that detected for healthy patients. EFFECT: higher accuracy and reliability of detection. 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSAY OF LEUKOCYTE FILTERING CAPACITY | 2002 |
|
RU2221249C1 |
METHOD OF DETERMINING INDIVIDUAL DOSE LOAD AT SUPERVASCULAR RADIATION OF BLOOD | 1996 |
|
RU2126969C1 |
METHOD FOR EARLIER DIAGNOSTICS OF BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES | 2000 |
|
RU2190221C2 |
METHOD FOR PREDICTING THE STATE OF INFLAMMATORY PROCESS AT PNEUMONIA | 2000 |
|
RU2193196C2 |
METHOD TO MODEL CHRONIC PLACENTAL INSUFFICIENCY | 1994 |
|
RU2092906C1 |
METHOD FOR TREATING UREMIC SYNDROME | 2001 |
|
RU2201755C2 |
METHOD FOR CORRECTING THE SYSTEM FOR ANTIOXIDANT PROTECTION AT DESTRUCTIVE PANCREATITIS | 2001 |
|
RU2186592C1 |
METHOD OF DETERMINING ACTIVITY OF COMPLEMENT, AND GEL INTENDED FOR USE IN THIS METHOD | 1996 |
|
RU2124209C1 |
METHOD FOR INTEGRAL EVALUATING THE POWER OF PROTEIN-LIPID INTERACTION IN ERYTHROCYTIC MEMBRANE | 2001 |
|
RU2187112C1 |
METHOD OF THE PROGRAMMED PLASMAPHORESIS | 1994 |
|
RU2103016C1 |
Authors
Dates
2003-05-10—Published
2001-02-08—Filed